Michael Welsh | Genetics and Molecular Biology | Best Researcher Award

Published on by Shen Awards

Prof. Michael Welsh |Genetics and Molecular Biology | Best Researcher Award

Uppsala University, Sweden

Professor J. Michael Welsh is an internationally recognized biomedical scientist renowned for his pioneering research in the field of medical cell biology, particularly focusing on cystic fibrosis, epithelial ion transport, and pulmonary disease mechanisms. As a leading figure in translational medicine, Professor Welsh has made groundbreaking discoveries that have reshaped the global understanding of cystic fibrosis pathophysiology, contributing directly to the development of therapeutic strategies that have improved patient outcomes worldwide. His research has centered on the molecular and cellular basis of epithelial ion channel dysfunction, elucidating the mechanisms by which CFTR gene mutations cause abnormal chloride transport and disrupted mucociliary clearance in the airways. Throughout his distinguished career, Professor Welsh has authored over 610 peer-reviewed publications, accumulating more than 62,725 citations and achieving an h-index exceeding 130, underscoring his far-reaching influence in the biomedical community. His scholarly excellence and innovation have earned him election to the U.S. National Academy of Sciences and the National Academy of Medicine, reflecting his standing as one of the foremost authorities in molecular physiology and genetics. In addition to his scientific achievements, Professor Welsh has demonstrated exemplary leadership as the founder of the University of Iowa Cystic Fibrosis Research Center, fostering cross-disciplinary collaborations with clinicians, geneticists, and pharmaceutical scientists to accelerate the translation of basic research into clinical applications. Professor Welsh’s research has profoundly influenced not only molecular medicine but also public health, by shaping therapeutic approaches that extend life expectancy and quality of life for individuals affected by genetic and respiratory diseases. His mentorship of emerging scientists and his commitment to collaborative, patient-centered innovation exemplify his enduring contribution to science and society. Through his visionary work, Professor Welsh continues to bridge the gap between molecular discovery and clinical transformation, embodying the essence of global scientific excellence and impact.

Profiles: Scopus | ORCID

Featured Publications

  1. Celis, N., Miller, D. P., Tarara, T. E., Weers, J. G., Thornell, I. M., Welsh, M. J., & Burke, M. D. (2025). Molecular prosthetics and CFTR modulators additively increase secretory HCO3− flux in cystic fibrosis airway epithelia. bioRxiv.

  2. Welsh, M. J. (2025, September 11). Rewriting the chapter on cystic fibrosis. JAMA.

  3. Welsh, M. J. (2025, August 10). A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adults. Journal of Parkinson’s Diseases.

  4. Thornell, I. M., Lei, L., McCray, P. B. Jr., & Welsh, M. J. (2025). Do pulmonary ionocytes absorb chloride or secrete chloride? American Journal of Physiology-Cell Physiology.

  5. Karp, P., Welsh, M., Kim, B. R., Keen, H., Rauckhorst, A. J., Taylor, E. B., Chimenti, M. S., & Rehman, T. (2025, January 24). The oxygen level in air directs airway epithelial cell differentiation by controlling mitochondrial citrate export. Science Advances.

Professor Michael Welsh’s work has revolutionized the understanding and treatment of cystic fibrosis by uncovering the molecular mechanisms of CFTR dysfunction, leading to life-changing therapies for patients worldwide. His groundbreaking research bridges molecular biology and clinical medicine, driving global innovation in genetic disease treatment and advancing precision healthcare.

Pingdong Lin | Agricultural and Biological Sciences | Best Researcher Award

Published on by Shen Awards

Dr. Pingdong Lin | Agricultural and Biological Sciences | Best Researcher Award

Institute of Animal Husbandry and Veterinary Medicine Fujian Academy of Agricultural Sciences, China

Dr. Pingdong Lin, Ph.D., is an accomplished researcher and Assistant Research Fellow at the Institute of Animal Husbandry and Veterinary Medicine, Fujian Academy of Agricultural Sciences, whose expertise lies at the intersection of biochemistry, molecular biology, and agricultural biotechnology. He earned his Ph.D. in Biochemistry and Molecular Biology from Fujian Normal University (2019–2023), an M.S. in Pharmaceutical Analysis (2013–2016), and a B.S. in Food Science and Engineering (2009–2013), both from Fujian University of Traditional Chinese Medicine. Throughout his career, Dr. Lin has developed strong research foundations through his professional journey as a Postdoctoral Fellow at the School of Life Sciences, Fujian Normal University, and Fujian Fuda Biotech Co., Ltd., as well as a Research Assistant at the Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences. His key research interests include the extraction, development, and utilization of plant functional components, green feed additive innovation, and the application of Chinese herbal medicine in improving poultry health and productivity. Dr. Lin’s research achievements include serving as Principal Investigator for a project funded by the Fujian Academy of Agricultural Sciences and contributing to multiple provincial-level programs such as the Fujian Provincial Natural Science Foundation Youth Innovation and General Program projects, as well as the Fujian Spark Program. He has published more than 15 research papers as first or co-first author, including several SCI-indexed journals, and holds one National Invention Patent. His research skills encompass molecular and biochemical analysis, feed formulation, and herbal compound extraction, demonstrating a balance between laboratory precision and practical agricultural application. Recognized for his innovative approach and interdisciplinary expertise, Dr. Pingdong Lin continues to contribute to sustainable animal farming through scientific excellence and the integration of traditional medicinal knowledge with modern biotechnological advances.

Profile: ORCID

Featured Publications

  1. Lin, P., Yue, W., Xiang, H., Liu, J., & Chen, X. (2025, October 10). Investigating the effects of Gardenia polysaccharides on LPS-induced immune injury in mice and exploring the molecular mechanisms underlying its regulatory effect on the immune function of macrophages. Foods, 14(20), 3455.

  2. Lin, P., Chen, L., Huang, X., Xiao, F., Fu, L., Jing, D., Wang, J., Zhang, H., Sun, L., & Wu, Y. (2022, September 24). Structural characteristics of polysaccharide GP2a in Gardenia jasminoides and its immunomodulatory effect on macrophages. International Journal of Molecular Sciences, 23(19), 11279.

  3. Zheng, W., Lin, P., Ma, Y., Shao, X., Chen, H., Chen, D., Liu, X., Li, X., & Ye, H. (2017, November). Psoralen promotes the expression of cyclin D1 in chondrocytes via the Wnt/β-catenin signaling pathway. International Journal of Molecular Medicine, 40(5), 1585–1592.

  4. Lin, P., Weng, X., Liu, F., Ma, Y., Chen, H., Shao, X., Zheng, W., Liu, X., Ye, H., & Li, X. (2015, December). Bushen Zhuangjin decoction inhibits TM-induced chondrocyte apoptosis mediated by endoplasmic reticulum stress. International Journal of Molecular Medicine, 36(6), 1513–1520.

  5. Weng, X., Lin, P., Liu, F., Chen, J., Li, H., Huang, L., Zhen, C., Xu, H., Liu, X., & Ye, H. (2014, October). Achyranthes bidentata polysaccharides activate the Wnt/β-catenin signaling pathway to promote chondrocyte proliferation. International Journal of Molecular Medicine, 34(4), 1045–1050.

Dr. Pingdong Lin’s work bridges traditional Chinese herbal medicine and modern biotechnology to develop sustainable, health-promoting feed additives for the livestock industry. His research advances green agriculture, enhances animal welfare, and supports global efforts toward eco-friendly and resilient food production systems.

Yi Tian | Immunology and Microbiology | Best Researcher Award

Published on by Shen Awards

Yi Tian | Immunology and Microbiology | Best Researcher Award

Cangzhou Medical College | China

Hundasa Chala Nagari is a committed researcher and academic whose career reflects dedication to advancing science and contributing to education and innovation. He completed his undergraduate and postgraduate studies with distinction, building a strong foundation in science and engineering, and pursued advanced research training that shaped his expertise in sustainable development, environmental impact, and technological applications. Professionally, he has worked in teaching and research roles, mentoring students, engaging in collaborative projects, and contributing to institutional growth through active participation in academic and community initiatives. His research interests focus on energy efficiency, climate impact, materials behavior, and the application of interdisciplinary approaches that connect theory with practical solutions to societal challenges. He has conducted projects that address pressing global issues, including renewable energy systems and sustainable resource management, producing publications in peer-reviewed journals and presenting findings at international conferences. His research skills include experimental design, computational modeling, data analysis, and scientific writing, complemented by strong communication, teamwork, and leadership abilities that enable him to guide students and collaborate effectively with colleagues. In addition to technical expertise, he has demonstrated initiative in expanding research networks and enhancing academic visibility through cross-border collaborations. His contributions have been recognized with academic awards, research fellowships, and honors that highlight both his achievements and his potential to lead future scientific innovation. In conclusion, Hundasa Chala Nagari stands out as a promising academic whose education, professional experience, research interests, skills, and honors reflect his capability to contribute meaningfully to global research, and his vision of expanding high-impact publications, international collaborations, and leadership roles makes him a deserving candidate for recognition in research and innovation.

Profile: Scopus

Featured Publication

  1. The role of the Wiskott–Aldrich syndrome protein family in cancer development, invasion, and metastasis

 

Neng Jiang | Biochemistry | Best Researcher Award

Published on by Shen Awards

Dr. Neng Jiang | Biochemistry | Best Researcher Award

Sun Yat-sen University Cancer Center | China

Dr. Neng Jiang is a highly accomplished pathologist and cancer researcher, recognized for his expertise in angiogenesis and stem cell biology within the context of lung cancer. With both an MD and a Ph.D., he has established himself as a leading academic and clinical researcher at the Department of Pathology, Sun Yat-sen University Cancer Center in Guangzhou, China, one of Asia’s foremost institutions for oncology research. His career is defined by a commitment to advancing diagnostic pathology and deepening the understanding of cancer mechanisms, with a focus on bridging molecular discoveries with real-world clinical applications. Over the years, Dr. Jiang has authored multiple publications in high-impact international journals indexed in Scopus, PubMed, and Web of Science, contributing valuable knowledge to the global medical community. His ability to integrate clinical observations with experimental research has positioned him as a crucial contributor to translational oncology, enabling better strategies for early detection and targeted therapies. Through international collaborations and active engagement in academic forums, he has established a strong global presence. With a career dedicated to advancing cancer research and improving patient outcomes, Dr. Jiang exemplifies the role of a researcher whose work drives innovation, education, and clinical transformation in modern oncology.

Professional Profile

Education

Dr. Neng Jiang’s academic foundation is firmly rooted in medicine and research, reflecting his dual training as a clinician and scientist. He pursued his Doctor of Medicine (MD) with a specialization in pathology, equipping him with extensive knowledge of human disease processes and diagnostic methodologies. Following his medical degree, he undertook a Doctor of Philosophy (Ph.D.) in Oncology and Pathology, which allowed him to explore advanced mechanisms of cancer development, particularly angiogenesis and cancer stem cell biology. His Ph.D. research, conducted at Sun Yat-sen University Cancer Center, emphasized the tumor microenvironment and molecular factors influencing cancer progression, with findings that contributed to the academic literature in the field. Throughout his education, Dr. Jiang actively engaged in research activities, conference presentations, and collaborative projects, which strengthened both his theoretical and practical understanding of oncology. His commitment to academic excellence is reflected in his strong track record of publications during his doctoral studies. By combining clinical medical training with rigorous scientific inquiry, Dr. Jiang’s education uniquely prepared him to bridge the gap between laboratory research and patient care, laying the foundation for his impactful career in pathology and oncology research at national and international levels.

Professional Experience

Dr. Neng Jiang’s professional career has been characterized by his contributions to both clinical pathology and academic research. He currently serves at the Department of Pathology, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, one of the most prestigious oncology research institutions in China. In this role, he has been deeply involved in diagnostic pathology while leading projects that investigate the biological basis of cancer progression. His experience extends across collaborative clinical studies, translational research, and guiding younger researchers in pathology-related investigations. Dr. Jiang has worked extensively with multidisciplinary teams, both domestically and internationally, enabling him to contribute to projects that integrate clinical practice with laboratory innovation. His professional portfolio includes participation in major research initiatives aimed at improving cancer diagnostics, treatment strategies, and biomarker discovery. He has also presented his work at leading scientific conferences, where he has shared critical insights with the global pathology and oncology community. Beyond his research and clinical commitments, Dr. Jiang plays a role in academic mentorship, training medical students and junior researchers, thereby fostering the next generation of cancer scientists. His professional journey highlights a balance of leadership, innovation, and dedication to advancing oncology.

Research Interests

Dr. Neng Jiang’s primary research interests lie at the intersection of angiogenesis, stem cell biology, and lung cancer pathology, areas that are central to understanding tumor initiation, growth, and metastasis. He has a particular focus on the molecular pathways and tumor microenvironmental factors that drive cancer progression, with the ultimate aim of developing more effective therapeutic interventions. His work explores how abnormal vascular growth supports cancer survival and how cancer stem cells contribute to resistance to therapy and recurrence. In addition to lung cancer, he has engaged in research that evaluates biomarkers for cancer diagnosis and prognosis, contributing to precision medicine approaches in oncology. Dr. Jiang’s research interests also include translational applications, where discoveries in the laboratory are applied to clinical settings, bridging the gap between basic science and patient care. By combining pathology expertise with molecular research, he aims to identify novel targets for anti-cancer therapies and improve strategies for early cancer detection. His dedication to these research areas is evident in his growing body of publications in high-impact journals and his collaborations with international experts. This focus ensures that his work continues to make meaningful contributions to both academic research and clinical oncology practice.

Research Skills

Over the course of his academic and professional career, Dr. Neng Jiang has developed an extensive range of research skills that make him highly effective in cancer pathology and translational oncology. His expertise spans both laboratory-based and clinical methodologies. He is proficient in histopathology, immunohistochemistry, molecular diagnostics, and biomarker analysis, enabling him to provide detailed insights into tumor biology. Dr. Jiang has also mastered experimental techniques related to cell culture, angiogenesis assays, and stem cell studies, which are vital for investigating mechanisms of tumor growth and resistance. Beyond laboratory skills, he has strong experience in scientific writing, data interpretation, and statistical analysis, ensuring his research is rigorous and impactful. His ability to integrate clinical observations with molecular-level data distinguishes his work and allows him to develop comprehensive approaches to cancer research. Additionally, Dr. Jiang is adept at working in multidisciplinary research environments, coordinating with oncologists, molecular biologists, and clinicians to achieve common goals. He also has experience with international research platforms, presenting findings at conferences and contributing to global scientific dialogues. These skills, combined with his clinical training, position him as a well-rounded researcher capable of delivering impactful contributions to modern oncology.

Awards and Honors

Throughout his career, Dr. Neng Jiang has received recognition for his outstanding contributions to pathology and oncology research. His awards reflect both academic excellence and research innovation. He has been acknowledged for his impactful publications in high-impact journals, many of which focus on lung cancer pathology, angiogenesis, and stem cell biology. His work has contributed to the development of novel diagnostic and therapeutic approaches, earning him recognition at both national and international scientific forums. Dr. Jiang has also been invited to present his findings at leading conferences, where his presentations have received commendation for advancing the field of oncology. In addition to publication-related achievements, he has been honored with institutional awards from Sun Yat-sen University Cancer Center, recognizing his leadership and research excellence. His active participation in academic committees and professional societies has further solidified his standing as a respected member of the scientific community. While his career continues to evolve, the honors he has already received demonstrate his capacity for innovation, his dedication to patient-centered research, and his role as a thought leader in cancer pathology. These recognitions highlight his potential for future breakthroughs and leadership in global oncology research.

Publication Top Note

  • Defining homologous recombination deficiency status in pancreatic ductal adenocarcinoma: Clinical implications for evaluating response to platinum chemotherapy — 2025

Conclusion

In conclusion, Dr. Neng Jiang is a distinguished pathologist and oncology researcher whose career reflects a remarkable blend of academic excellence, clinical expertise, and research innovation. With his dual qualifications of MD and Ph.D., he has developed an in-depth understanding of cancer biology, particularly focusing on angiogenesis and stem cell pathways in lung cancer. His research contributions, published in reputed journals and presented at international conferences, have advanced knowledge in cancer pathology and created new avenues for therapeutic strategies. Professionally, he has played a critical role at the Sun Yat-sen University Cancer Center, where he combines clinical diagnostics with pioneering research initiatives. His skills in molecular diagnostics, translational research, and scientific leadership make him a valuable contributor to both academia and clinical oncology. Recognized with multiple awards and honors, Dr. Jiang’s career demonstrates consistent excellence and a commitment to improving patient outcomes. Looking forward, his ongoing dedication to research and collaboration promises further advancements in cancer detection and treatment. These qualities make him a deserving candidate for international recognition, particularly the Best Researcher Award, as he continues to shape the future of pathology and oncology at both national and global levels.

Aurora Daniele | Biochemistry | Best Researcher Award

Published on by Shen Awards

Prof. Dr. Aurora Daniele | Biochemistry | Best Researcher Award

University of Naples Federico II | Italy

Prof. Dr. Aurora Daniele is an accomplished academic and researcher with more than three decades of contributions to the fields of molecular biology, genetics, and biochemistry. Currently serving as a Full Professor at the Università degli Studi di Napoli “Federico II,” she has established herself as an influential figure in biomedical sciences with a broad focus ranging from enzymatic pathways and protein biosynthesis to lysosomal storage disorders and molecular diagnostics. Her career reflects a remarkable blend of academic leadership, impactful research, and international collaboration. Prof. Daniele has published extensively in top-tier journals, authoring over 136 scientific papers indexed in Scopus, Web of Science, and PubMed. With an h-index of 30 and more than 2,700 citations, her research is widely recognized and cited globally. She has collaborated with institutions such as the Mayo Clinic in the United States and played a pivotal role as Principal Investigator at CEINGE – Biotecnologie Avanzate. Beyond research, she has contributed to academic governance, serving as President of the School of Food and Nutrition Sciences at the University of Campania “L. Vanvitelli.” Through her outstanding work, Prof. Daniele has significantly advanced knowledge in life sciences while shaping the next generation of scholars and practitioners.

Professinal Profile

Scopus | ORCID

Education

Prof. Dr. Aurora Daniele’s academic journey began with a strong foundation in the life sciences. She pursued her degree in Biological Sciences at the Università degli Studi di Napoli “Federico II,” where she developed a keen interest in molecular biology, genetics, and biochemical research. Her rigorous training at this historic university provided her with both theoretical depth and practical expertise, enabling her to engage in cutting-edge research from the early stages of her career. Following her initial studies, she sought advanced scientific exposure through national and international fellowships, most notably at the Telethon Institute of Genetics and Medicine in Milan, Italy. During this formative period, she focused on molecular diagnostics, genetic regulation, and the study of metabolic pathways. These opportunities enriched her scientific outlook, broadening her expertise in clinical molecular biology and the application of advanced biotechnological methods. Her educational background, deeply rooted in one of Italy’s oldest and most prestigious institutions, provided the strong academic and research orientation that continues to guide her career today. This blend of local academic grounding and global research training has allowed Prof. Daniele to establish herself as a thought leader in genetics and molecular diagnostics.

Professional Experience

Prof. Dr. Aurora Daniele has an extensive record of academic leadership and professional achievements. She currently serves as Full Professor at the Università degli Studi di Napoli “Federico II,” where she has taught and mentored undergraduate, graduate, and doctoral students in life sciences, biochemistry, and genetics. Her professional trajectory includes notable leadership roles, such as her tenure as President of the School of Food and Nutrition Sciences at the University of Campania “L. Vanvitelli”. In addition, she has contributed significantly to clinical and translational research as Principal Investigator at CEINGE – Biotecnologie Avanzate, an advanced biotechnology research center in Naples. Her professional career has been marked by consistent efforts to integrate molecular diagnostics into clinical applications, advancing both science and healthcare. Prof. Daniele has also played an essential role in fostering collaborations with international institutions, including the Mayo Clinic in the United States, thereby broadening the impact of her research beyond Italy. As an educator and scientist, she has successfully combined laboratory innovation with academic leadership, resulting in a career that influences policy, teaching, and medical practice. Her professional achievements highlight her as a leader in Italian and international biomedical research.

Research Interests

Prof. Dr. Aurora Daniele’s research interests lie at the intersection of molecular biology, genetics, and clinical biochemistry. Her work primarily focuses on enzymatic pathways, protein biosynthesis, and the molecular mechanisms underlying lysosomal storage disorders. She has dedicated significant research efforts to understanding genetic regulation and transcriptomic responses, with particular attention to the signaling pathways involved in metabolic and degenerative diseases. Another central aspect of her research is the development and application of molecular diagnostic tools aimed at identifying genetic disorders and optimizing clinical interventions. She is equally interested in transcriptomic and proteomic studies, which provide a broader systems-level understanding of disease pathophysiology. Over the years, Prof. Daniele has expanded her research to include clinical molecular diagnostics, with an emphasis on bridging laboratory science and patient care. She has also contributed to the study of nutritional sciences, linking metabolism to molecular pathways, thereby highlighting the interplay between diet, genetics, and health outcomes. Her wide-ranging interests have allowed her to contribute meaningfully to both fundamental science and applied medicine, positioning her as a key figure in advancing knowledge in biomedicine, diagnostics, and personalized healthcare.

Research Skills

Prof. Dr. Aurora Daniele possesses a highly diverse and advanced skill set in molecular biology, biochemistry, and genetics. She is proficient in enzymatic assays, protein expression and purification techniques, and the analysis of signaling pathways critical to cellular function. Her expertise extends to transcriptomic and proteomic technologies, enabling her to study gene expression regulation and protein interactions at a systems biology level. Additionally, she has advanced skills in clinical molecular diagnostics, which she has applied in both laboratory and translational settings to improve the detection and understanding of genetic disorders. Prof. Daniele is skilled in molecular cloning, PCR, electrophoresis, and biochemical analysis of cellular mechanisms. Her research also demonstrates proficiency in developing and validating biomarkers for disease, particularly in lysosomal storage disorders. Beyond laboratory methods, she is adept at scientific writing, project leadership, and cross-disciplinary collaboration, often integrating expertise from different research domains. Her ability to combine technical precision with conceptual innovation has made her a valuable contributor to both basic and applied research. These skills, acquired over decades of work, form the backbone of her impactful contributions to modern biomedical sciences.

Awards and Honors

Throughout her career, Prof. Dr. Aurora Daniele has received recognition for her exceptional contributions to biomedical research and academic leadership. She has been consistently acknowledged for her role in advancing molecular biology and clinical biochemistry, as well as for her leadership positions within prestigious Italian universities. Serving as President of the School of Food and Nutrition Sciences at the University of Campania “L. Vanvitelli” reflects her academic excellence and administrative capabilities. Her extensive publication record, with over 136 papers indexed in Scopus, PubMed, and Web of Science, further testifies to her global recognition. With an h-index of 30 and over 2,700 citations, her influence within the scientific community is substantial. Beyond metrics, she has been invited to collaborate with international research institutions, including the Mayo Clinic, underscoring the value of her expertise in global biomedical research. While specific awards and formal honors add to her distinction, her career itself stands as a testament to sustained excellence, mentorship, and leadership. Her recognition is rooted not only in academic circles but also in her meaningful impact on advancing diagnostics, therapeutic strategies, and higher education.

Publication Top Notes

  • Exploring the role of serum adiponectin and its holigomerization in fibrotic interstitial lung diseases: results from a cross-sectional study — 2025

  • β-Hydroxybutyrate mitigates the detrimental effects of high glucose in human retinal pigment epithelial ARPE-19 cells — 2025

  • Adiponectin and HMW Oligomers in Relation to Inflammatory Markers in Crohn’s Disease Patients — 2025

  • Plasma adiponectin levels are associated with habitual dietary polyphenol intake in individuals at high cardiometabolic risk: a cross-sectional study — 2025

  • Exploring the Link Between Psoriasis and Adipose Tissue: One Amplifies the Other — 2024 — 2 citations

  • Impact of Lifestyle Interventions on Multiple Sclerosis: Focus on Adipose Tissue — 2024 — 3 citations

  • Effects of Exhaustive Exercise on Adiponectin and High-Molecular-Weight Oligomer Levels in Male Amateur Athletes — 2024 — 1 citation

  • LncRNA microarray profiling identifies novel circulating lncRNAs in hidradenitis suppurativa — 2024 — 3 citations

Conclusion

Prof. Dr. Aurora Daniele exemplifies the qualities of an outstanding researcher, educator, and leader in the fields of molecular biology, genetics, and biochemistry. With a career spanning more than three decades, she has consistently contributed to advancing both fundamental science and applied clinical practices. Her extensive research output, collaborations with international institutions, and leadership roles within Italian academia reflect her ability to integrate innovation, mentorship, and governance. She has effectively bridged laboratory research with healthcare applications, particularly in molecular diagnostics and metabolic disorders, thereby enhancing both scientific understanding and patient outcomes. Her skills, ranging from enzymatic assays to proteomic studies, highlight her versatility and technical excellence, while her publication record demonstrates her influence and recognition within the global scientific community. Prof. Daniele’s dedication to education has further amplified her impact, preparing the next generation of scientists and healthcare professionals. Her professional journey underscores a balance of academic rigor, international collaboration, and scientific creativity, making her a true leader in biomedical sciences. With her ongoing research and visionary outlook, she continues to shape the future of diagnostics, molecular medicine, and higher education, deserving recognition at the highest levels.

Wen Ni | Health Professions | Best Researcher Award

Published on by Shen Awards

Dr. Wen Ni | Health Professions | Best Researcher Award

Associate Professor from Sun Yat-sen University, China

Dr. Wen Ni is a distinguished academic and researcher currently serving as a Professor at Sun Yat-sen University, China. Her primary research interests lie in the fields of molecular pathology, cancer biology, and translational medicine. With a profound commitment to understanding the mechanisms of disease progression, Dr. Ni has made significant strides in identifying potential biomarkers and therapeutic targets for gastrointestinal and hepatic cancers. Her work is recognized both nationally and internationally, supported by high-impact publications and funded collaborative research projects. Beyond her scientific contributions, she plays an active role in mentoring the next generation of scientists, overseeing graduate students and contributing to institutional research excellence. Dr. Ni’s multi-disciplinary approach, which merges clinical relevance with molecular techniques, continues to drive impactful discoveries. She has also contributed extensively to academic literature, participated in professional societies like ASIP, and served in several advisory and peer-review capacities. Her role as a bridge between research and healthcare reflects her vision for a science-driven, patient-centric future. Dr. Ni remains an influential figure in her domain, representing a strong blend of research leadership, collaborative mindset, and community dedication.

Professional Profile

Education

Dr. Wen Ni pursued her academic training in the biological sciences, culminating in a Ph.D. in Pathology from Sun Yat-sen University. She earned her Bachelor’s degree in Biology from a leading Chinese university, followed by a Master’s degree in Cellular and Molecular Biology. Her doctoral research focused on tumor microenvironment modulation and its implications for hepatocellular carcinoma. This foundational education laid the groundwork for her career in pathology and oncology research. Throughout her academic journey, she has remained engaged in continued professional development, completing advanced training programs and postdoctoral research in specialized fields like translational oncology, immunohistochemistry, and gene expression analysis. Dr. Ni also participated in exchange programs and workshops sponsored by top-tier institutions across Asia and Europe, broadening her scientific perspective and cross-cultural research understanding. Her comprehensive educational background not only equipped her with essential technical expertise but also instilled a drive for interdisciplinary innovation and collaborative research. Today, her educational foundation supports a dynamic research career focused on real-world applications in precision medicine and diagnostic pathology.

Professional Experience

Dr. Wen Ni’s professional experience spans over a decade of academic, clinical, and research-focused roles. She currently holds the position of Professor at Sun Yat-sen University, where she heads a cancer biology lab within the School of Basic Medical Sciences. Her professional journey began as a research assistant in molecular biology, gradually advancing through roles such as Lecturer, Associate Professor, and now full Professor. She has led and co-led multiple national projects funded by the National Natural Science Foundation of China (NSFC), and has served as a key investigator in international research consortia. Apart from research, Dr. Ni has contributed significantly to curriculum development and teaching at both undergraduate and postgraduate levels. Her experience includes organizing academic conferences, leading student research symposia, and serving on the university’s scientific advisory boards. Dr. Ni is also frequently invited to provide expert reviews for peer-reviewed journals and grant funding agencies. Her hands-on involvement in both academic and applied research projects, combined with strategic leadership in institutional planning, reflects a well-rounded professional experience dedicated to scientific advancement and higher education excellence.

Research Interest

Dr. Wen Ni’s research interests lie primarily in the fields of molecular pathology, cancer diagnostics, and translational medicine. Her work centers around understanding the molecular and cellular mechanisms of carcinogenesis, particularly in gastrointestinal and hepatic cancers. She is passionate about decoding tumor heterogeneity, metastasis pathways, and immune microenvironments using advanced bioinformatics, single-cell sequencing, and in vitro/in vivo models. A significant focus of her current research includes the identification of early diagnostic markers and therapeutic targets for liver and colorectal cancers. Dr. Ni also explores epigenetic regulation and non-coding RNAs in tumor progression. Her translational research approach bridges laboratory findings with clinical applications, making her studies relevant for both the bench and the bedside. In addition, she is increasingly integrating artificial intelligence and machine learning in pathological image analysis to support precision oncology. Her future interests involve deeper collaborations in international projects focusing on global cancer epidemiology and therapeutic innovation. Dr. Ni remains committed to pushing boundaries in research that can significantly impact early detection, prognostication, and personalized treatment strategies in cancer care.

Research Skills

Dr. Wen Ni possesses a comprehensive range of research skills that support her advanced work in cancer biology and pathology. Her technical expertise includes molecular cloning, western blotting, PCR, flow cytometry, and CRISPR-Cas9 gene editing. She is proficient in histopathological techniques such as immunohistochemistry (IHC), immunofluorescence, and in situ hybridization, which are critical for tissue-based diagnostics. Dr. Ni also excels in high-throughput sequencing data analysis, including RNA-seq, microarray interpretation, and bioinformatics toolkits like R, SPSS, and Python-based analytics. She has experience handling animal models for tumorigenesis studies and conducting preclinical drug testing in vivo. Moreover, she has led teams in grant writing, project proposal development, and inter-institutional research collaborations. Dr. Ni is also skilled in manuscript preparation, scientific presentation, and academic mentoring. Her ability to integrate experimental and computational biology ensures a holistic approach to scientific inquiry. She emphasizes ethical research practices, lab safety protocols, and robust data management. These multifaceted research skills make her a valuable contributor to multidisciplinary studies and a mentor capable of training emerging scientists for careers in academia and industry.

Awards and Honors

Dr. Wen Ni has received several prestigious awards and honors throughout her academic and research career. She was honored with the Outstanding Young Investigator Award from Sun Yat-sen University for her pioneering work in molecular oncology. Her contributions to cancer diagnostics earned her recognition from the Chinese Society of Pathology, where she was presented with the Excellence in Research Award. She has been a recipient of multiple NSFC research grants, including young scholar support schemes. Internationally, Dr. Ni was selected as a visiting research fellow under the Sino-European Research Exchange Program, facilitating academic exchange with top institutions in Germany and the UK. Her conference presentations at ASIP, AACR, and the International Conference on Molecular Medicine have been well-received, earning her “Best Paper” and “Outstanding Poster” accolades. She has also been nominated to editorial boards of emerging journals in pathology and translational medicine. These awards reflect her continued excellence, innovation, and dedication in advancing scientific knowledge and shaping the next generation of biomedical researchers.

Conclusion

Dr. Wen Ni exemplifies academic excellence, research innovation, and a commitment to societal impact through science. Her leadership in cancer biology research, extensive publications, and international collaborations highlight a career built on quality, relevance, and collaboration. She has significantly contributed to the understanding and application of translational pathology, particularly in developing novel diagnostics and therapeutics. Her influence extends beyond the lab through teaching, mentoring, and involvement in professional scientific communities. Dr. Ni’s profile reflects an ideal candidate for recognition as a top-tier researcher making a global impact. Looking forward, she is poised to lead cross-border research initiatives, contribute to the global fight against cancer, and serve as an inspirational figure for aspiring scientists. Her vision, integrity, and scientific rigor make her an invaluable asset to the research community and a deserving recipient of prestigious international awards.

Honghui Tang | Immunology and Microbiology | Best Researcher Award

Published on by Shen Awards

Mrs. Honghui Tang | Immunology and Microbiology | Best Researcher Award

Deputy Chief Technician from Center of Clinical Laboratory and Translational Medicine, The Fourth Affiliated Hospital of Soochow University, Suzhou Dushu Lake Hospital, China

Honghui Tang is an experienced clinical laboratory professional currently serving as the Associate Chief Technician and Supervisor of Clinical Biochemistry at the Clinical Testing Center of the Fourth Affiliated Hospital of Soochow University. With over 21 years of specialized experience, she has developed in-depth expertise in clinical biochemistry and immunological testing. Her career is distinguished by her focus on quality management, laboratory standardization, and diagnostic excellence. She plays a key role in implementing the ISO 15189 accreditation system, designing and enforcing SOP frameworks, and ensuring efficient, accurate, and compliant laboratory operations. Tang is proficient in handling a variety of automated biochemical and immunoassay analyzers and leads the end-to-end diagnostic process. She is also deeply involved in interdepartmental collaboration to resolve complex diagnostic challenges and improve patient care outcomes. As a recognized professional, she serves as a member of the Clinical Biochemistry and Immunology Committee under the Laboratory Medicine Branch of the Suzhou Medical Association. Her leadership, technical competence, and commitment to healthcare advancement position her as a notable contributor in the field of laboratory medicine. While her focus has been more practice-oriented, she remains committed to expanding her engagement with research and evidence-based diagnostics.

Professional Profile

Education

Although the exact educational qualifications are not listed, it is evident that Honghui Tang has undergone advanced academic and professional training to attain the level of Associate Chief Technician in a prestigious clinical setting. Achieving such a role requires a strong educational foundation in clinical laboratory sciences, likely including a bachelor’s degree in Medical Laboratory Technology, Clinical Biochemistry, or a related field, followed by further specialization or advanced diplomas in laboratory diagnostics and quality management systems. Additionally, her ability to lead ISO 15189 implementation efforts and develop comprehensive SOP frameworks suggests extensive continuing education and training in laboratory accreditation protocols, biochemistry techniques, and health sciences management. Such a background is typically supplemented by practical hospital-based internships and certifications in biochemical and immunoassay technologies. As she operates in a university hospital setting and holds a supervisory position, it is also likely that she has participated in professional development programs offered by medical associations and institutional training initiatives. Her academic and technical education has enabled her to navigate complex diagnostic environments while ensuring quality, efficiency, and clinical accuracy.

Professional Experience

Honghui Tang brings over two decades of distinguished professional experience in clinical laboratory medicine, with her current role as Supervisor of Clinical Biochemistry at the Fourth Affiliated Hospital of Soochow University. She has been instrumental in shaping the operational standards of the Clinical Testing Center by implementing quality systems that align with international benchmarks, including ISO 15189. Her core responsibilities span the entire testing process—pre-analytical, analytical, and post-analytical phases—ensuring seamless workflow, error minimization, and clinical reliability. Tang is responsible for managing a wide array of automated instruments, including biochemical and immunoassay analyzers from leading manufacturers. She supervises equipment calibration, maintenance, and troubleshooting, guaranteeing uninterrupted laboratory operations. Her role demands daily interaction with clinicians, which she fulfills by advising on complex test results and refining diagnostic workflows. As a senior member of the laboratory, she also mentors junior staff, conducts training sessions, and enforces strict compliance with established standard operating procedures. Beyond the laboratory setting, she contributes to the broader medical community through her role on the Clinical Biochemistry and Immunology Committee of the Suzhou Medical Association. This combination of technical mastery and leadership underscores her status as a key pillar in her institution’s diagnostic excellence.

Research Interests

While Honghui Tang’s primary expertise lies in clinical laboratory practice, her work intersects significantly with applied research in diagnostic standardization and quality assurance. Her key research interests include the development and validation of diagnostic protocols in clinical biochemistry, the optimization of laboratory workflows for enhanced accuracy, and the implementation of ISO 15189 standards in clinical settings. She is also deeply invested in exploring strategies for minimizing analytical variability, increasing inter-laboratory result harmonization, and improving diagnostic turnaround time. Another area of interest is the clinical interpretation of immunological assay results in complex or ambiguous patient cases, especially in collaborative efforts with physicians for evidence-based medical decision-making. Her contributions have practical implications for diagnostic reliability and healthcare delivery, and her engagement with hospital-wide interdisciplinary case reviews presents unique opportunities for applied clinical research. With the right collaborations, she is well-positioned to contribute to scholarly work on laboratory accreditation, test performance evaluation, and diagnostic technology integration in modern hospital settings. As she continues her career, these research interests could be further developed through collaborative publications, quality improvement studies, and clinical trials focused on diagnostic biomarkers.

Research Skills

Honghui Tang possesses a wide range of advanced research skills rooted in clinical laboratory practice. She is highly proficient in operating and maintaining a variety of automated biochemical and immunoassay analyzers, which is essential for both diagnostic accuracy and research application. Her strengths include data quality management, implementation of international quality standards like ISO 15189, and development of laboratory standard operating procedures (SOPs)—key competencies that support research reproducibility and methodological rigor. Tang also brings expertise in analytical troubleshooting and validation of test results, including root-cause analysis for irregular findings. She is adept in documenting diagnostic workflows, preparing laboratory reports, and contributing to interdepartmental discussions to resolve complex cases. These practical experiences have equipped her with strong skills in data interpretation, assay performance monitoring, and evidence-based evaluation. Additionally, her work supervising other technicians and managing laboratory systems underscores her project management, documentation, and training abilities. Although she has yet to publish widely, her operational expertise provides a strong foundation for translational research and diagnostic innovation. Her technical fluency, especially in relation to test automation and quality assurance, makes her well-prepared to contribute to applied clinical research and collaborative investigations.

Awards and Honors

While no specific awards or honors are mentioned in the available information, Honghui Tang’s appointment as Associate Chief Technician and her leadership role in one of Soochow University’s affiliated hospitals are significant recognitions of her professional contributions. The trust placed in her to lead the Clinical Biochemistry section, oversee quality assurance, and implement accreditation standards such as ISO 15189 attests to her high level of competence and dedication. Furthermore, her selection as a committee member of the Clinical Biochemistry and Immunology Division of the Suzhou Medical Association reflects professional acknowledgment by her peers and industry leaders. These roles typically require demonstrated excellence in laboratory management, technical proficiency, and consistent contribution to healthcare services. Although formal honors such as national or international research awards are not listed, her career achievements indicate that she has earned institutional and professional respect. As she continues to engage more actively in research, particularly through collaborations and publications, she stands to receive additional recognition at the academic and scientific levels in the near future.

Conclusion

Honghui Tang exemplifies excellence in clinical laboratory science through her extensive experience, leadership, and technical acumen. Her 21-year career is marked by a commitment to diagnostic precision, quality management, and the continuous advancement of clinical laboratory operations. As Associate Chief Technician, she plays a pivotal role in standardizing procedures, implementing internationally recognized accreditation systems, and training new professionals. Her ability to operate across technical, managerial, and clinical dimensions makes her a vital contributor to patient care and hospital diagnostics. While her work is largely practice-oriented, she possesses a strong foundation for research, particularly in diagnostic standardization and quality assurance. Moving forward, increased participation in academic research and publication will enhance her professional profile and contribute to the scientific community. With her established expertise, leadership roles, and interest in applied research, Honghui Tang is a highly deserving candidate for the Best Researcher Award in the field of clinical laboratory science. Her work not only improves operational outcomes but also ensures the accuracy and integrity of patient diagnostics, reflecting the critical role of laboratory science in modern healthcare.

 

Azam Moosavi | Biochemistry | Best Researcher Award

Published on by Shen Awards

Dr. Azam Moosavi | Biochemistry | Best Researcher Award

R&D lab Manager/supervisor of innovation center of SCARM(Stem Cell and Regenerative Medicine) from Tabriz University of Medical Sciences, Iran

Dr. Azam Moosavi is a dedicated and innovative biochemist specializing in beta-cell regeneration for the treatment of Type 1 diabetes. With a strong academic foundation and a passion for interdisciplinary research, she integrates molecular biology, regenerative medicine, and clinical biochemistry in her scientific work. Over her academic and professional career, she has developed a notable track record in research, mentorship, and laboratory management. Her research aims to translate scientific findings into real-world applications, especially for chronic diseases like diabetes. She has contributed to several peer-reviewed publications, presented at major international conferences, and co-authored a book chapter on bioactive peptides. Currently serving as R&D and Cell Culture Lab Manager at the Innovation Center of Stem Cells and Regenerative Medicine at Tabriz University of Medical Sciences, Dr. Moosavi is also actively involved in mentoring young researchers. With additional expertise in teaching, clinical laboratory operations, and scientific writing, she brings a multifaceted approach to biomedical research. Her work demonstrates both academic rigor and practical impact, and she is highly regarded for her contributions to translational medicine, epigenetics, and molecular diagnostics. Dr. Moosavi continues to strive toward scientific excellence, combining curiosity with applied innovation in pursuit of better health solutions.

Professional Profile

Education

Dr. Azam Moosavi’s academic journey reflects her deep commitment to biomedical sciences and health research. She earned her Ph.D. in Biochemistry from the Institute of Biochemistry and Biophysics (IBB) at the University of Tehran, where her thesis focused on beta-cell regeneration in Type 1 diabetes through pharmaceutical induction. Her Ph.D. was marked by an impressive GPA (3.7/4) and resulted in multiple scientific presentations and publications. Prior to that, she completed a Master of Public Health (MPH) in Health Management and Reform at Tehran University of Medical Sciences, focusing on strategic risk management in health systems. She also holds an M.Sc. in Biochemistry from Tarbiat Moallem University in Tehran, where she investigated alpha thalassemia genetics, leading to multiple congress presentations. Dr. Moosavi began her academic training with a Bachelor of Science in Clinical Laboratory Sciences from Mashhad University of Medical Sciences, followed by an Associate degree in the same field from Tehran University of Medical Sciences. Her academic record is consistent, with GPA scores ranging from 3.3 to 3.9, showcasing a solid grasp of theory and practice. These multidisciplinary qualifications equip her with a robust foundation for both laboratory research and healthcare innovation.

Professional Experience

Dr. Moosavi brings over two decades of experience spanning research, laboratory management, and academic instruction. Since March 2023, she has served as R&D and Cell Culture Lab Manager at the Innovation Center of Stem Cells and Regenerative Medicine (SCARM), Tabriz University of Medical Sciences. Here, she supervises experimental design, oversees lab operations, mentors postgraduates, and contributes to cutting-edge regenerative research. Prior to this role, Dr. Moosavi spent ten years teaching biochemistry laboratory courses to medical, dental, and pharmacy students at Alborz University of Medical Sciences. Her instruction emphasized clinical applications and hands-on skills, significantly enhancing student competency in diagnostics. Between 2005 and 2013, she managed clinical laboratories in various health centers and at Kasra Hospital in Karaj, where she was responsible for quality control, team supervision, and staff training across hematology, microbiology, and biochemistry divisions. In addition to her formal roles, she has led workshops in quality control and hematology testing, implemented risk management strategies, and participated in numerous clinical and academic projects. Her professional journey is characterized by leadership in education, hands-on expertise in diagnostics, and a drive to integrate innovative research with public health practice.

Research Interests

Dr. Moosavi’s research interests are centered on the intersection of molecular biology, regenerative medicine, and clinical diagnostics. Her primary focus is on beta-cell regeneration as a therapeutic strategy for Type 1 diabetes—a condition she explores through pharmaceutical, genetic, and immunological lenses. She is particularly interested in cell-based models, gene regulatory networks, and high-tech therapeutic interventions aimed at reversing or halting disease progression. Her passion for stem cell biology and regenerative therapies is reflected in her involvement with mesenchymal stem cell research and the use of exosomes in clinical settings. Beyond diabetes, she has contributed to projects involving autoimmune disorders, fertility research, cancer diagnostics, and infectious diseases like COVID-19. Her work also explores epigenetic regulation, as evidenced by a highly cited publication on the role of epigenetics in human diseases. In addition, Dr. Moosavi is eager to integrate new technologies into her research, including artificial intelligence (AI), next-generation sequencing (NGS), and gene editing techniques. This interdisciplinary approach allows her to not only study disease mechanisms at the molecular level but also develop actionable, personalized treatment strategies. She continuously expands her research portfolio with a strong commitment to innovation and translational impact.

Research Skills

Dr. Moosavi has cultivated a wide array of research skills that span molecular techniques, computational analysis, and laboratory management. She is proficient in essential molecular biology methods including PCR, ELISA, Western blotting, and routine clinical laboratory testing. Her expertise also includes cell culture, particularly in managing regenerative medicine labs, as well as conducting experiments on the apoptotic effects of compounds and stem cell secretome applications. In addition to wet-lab skills, she is experienced in data analysis and literature management using tools like GraphPad Prism, RevMan5, and EndNote. Her training in Good Clinical Practice (GCP) and Good Manufacturing Practice (GMP) principles supports her ability to implement and monitor high-quality standards in laboratory settings. Moreover, she is well-versed in risk management using Failure Mode and Effects Analysis (FMEA), which she has applied to improve safety and operational efficiency in academic laboratories. With intermediate proficiency in English and basic command of German and Azerbaijani, she is also equipped for international collaboration. Altogether, her technical and analytical competencies allow her to conduct research that is both scientifically rigorous and aligned with current regulatory standards.

Awards and Honors

Dr. Azam Moosavi has received several notable recognitions throughout her academic and professional journey. She secured third place nationally in the Ph.D. entrance exam for biochemistry at the University of Tehran, reflecting her strong academic standing. Her contributions to the field of molecular biology and regenerative medicine have been acknowledged at prestigious conferences, including the Best Poster Award at the 17th National and 8th International Congress of Biochemistry and Molecular Biology in 2023. Additionally, she was selected as the first presenter in the Young Researchers’ Section at the 15th International & 21st National Congress on Quality Improvement in Clinical Laboratories in 2024. Beyond academic accolades, Dr. Moosavi holds a patent related to lung cancer antibody production using nanopharmaceutical technology, underscoring her innovation in translational research. She also earned third position in the National Industrial Innovation Competition, further recognizing her role in applied scientific development. These honors validate her dedication to excellence, whether in academic research, laboratory innovation, or public health impact. Collectively, these awards demonstrate Dr. Moosavi’s significant contributions to biomedical science and affirm her as a rising leader in the fields of biochemistry and regenerative medicine.

Conclusion

Dr. Azam Moosavi emerges as a well-qualified candidate for the Best Researcher Award, with extensive contributions to biochemistry, regenerative medicine, and clinical laboratory science. Her academic credentials, professional experience, and interdisciplinary research projects collectively demonstrate excellence in both theoretical and applied science. Through her focus on beta-cell regeneration for Type 1 diabetes, Dr. Moosavi has tackled a major public health challenge using innovative and translational approaches. Her record includes numerous peer-reviewed publications, international presentations, patents, and awards, positioning her as a leader in her field. She has also played a key role in education and mentorship, nurturing the next generation of biomedical researchers. With solid research skills, an expanding network of collaborations, and a commitment to continuous learning, Dr. Moosavi has built a career marked by impact, growth, and forward-thinking science. Moving forward, she is poised to make even greater contributions through high-impact research, interdisciplinary teamwork, and international engagement. Her profile exemplifies the qualities that the Best Researcher Award seeks to honor: intellectual rigor, practical innovation, and a drive to improve human health through science.

Publications Top Notes

  1. Beta Cell Regeneration upon Magainin and Growth Hormone Treatment as a Possible Alternative to Insulin Therapy
    Journal: FEBS Open Bio, 2023
    Authors: Azam Moosavi, Razieh Yazdanparast

  2. Human Herpesvirus 6 Infection and Risk of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis
    Journal: Intervirology, 2022
    Author: Azam Moosavi

  3. A Systematic Review and Meta-Analysis on the Epidemiology, Causal Agents and Demographic Characteristics of Onychomycosis in Iran
    Journal: Medical Mycology, 2019
    Author: Azam Moosavi

  4. Environmental Exposure to Endotoxin and Its Health Outcomes: A Systematic Review
    Journal: Ecotoxicology and Environmental Safety, 2019
    Author: Azam Moosavi

  5. The Frequency of Fungi Isolated from the Skin and Hair of Asymptomatic Cats in Rural Area of Meshkin-shahr, Iran
    Journal: Journal de Mycologie Médicale, 2019
    Authors: A. Moosavi, R.D. Ghazvini, K. Ahmadikia, S.J. Hashemi, M. Geramishoar, M. Mohebali, M.S. Yekaninejad, H. Bakhshi, M. Khodabakhsh

  6. The Frequency and Importance of Common α-globin Gene Deletions among β-thalassemia Carriers in an Iranian Population
    Journal: Avicenna Journal of Medical Biotechnology, 2017
    Authors: A. Moosavi, A.M. Ardekani

  7. Role of Epigenetics in Biology and Human Diseases
    Journal: Iranian Biomedical Journal, 2016
    Author: Azam Moosavi

  8. Bioactive Peptides
    Publisher: CRC Press, 2021
    Author: Azam Moosavi

  9. Effect of Vitamin B6 Supplementation on Biochemical Values in Type 2 Diabetes Mellitus
    Conference: Congress on Quality Improvement in Clinical Laboratories, 2015
    Author: Azam Moosavi

 

Willi Tarver | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Willi Tarver | Medicine and Dentistry | Best Researcher Award

Assistant Professor from The Ohio State University, United States

Dr. Willi L. Tarver is a distinguished Assistant Professor in the Division of Cancer Prevention and Control at The Ohio State University, where he leverages his interdisciplinary expertise to address disparities in healthcare delivery and cancer outcomes. With a strong foundation in public health informatics, behavioral oncology, and medical library sciences, Dr. Tarver’s research focuses on integrating patient-reported outcomes (PROs), electronic tools, and equity-focused interventions to better engage underserved populations in the cancer care continuum. His professional trajectory includes advanced fellowships in behavioral oncology and medical informatics, and he is actively involved in federally funded research projects. Dr. Tarver is also deeply committed to mentoring students and early-career professionals, especially from underrepresented backgrounds. His scholarly work addresses systemic issues in healthcare access and aims to develop scalable, tech-based strategies to reduce disparities. In addition to research and teaching, he plays key roles in administrative and clinical improvement initiatives within OSU’s Quality Improvement Hub. Dr. Tarver’s growing leadership within national organizations, innovative approach to equitable cancer prevention, and consistent focus on translating research into real-world applications position him as a leader in academic medicine and public health. He is a compelling nominee for the Best Researcher Award.

Professional Profile

Education

Dr. Tarver’s educational background reflects a unique and valuable combination of public health, information science, and communication, which together form the backbone of his interdisciplinary research. He earned his Doctor of Public Health (Dr.P.H.) from the University of Alabama at Birmingham, where he was also a recipient of the prestigious NCI Diversity Supplement under the Cancer Prevention and Control Training Program. Prior to this, he completed dual Master’s degrees in Public Health (MPH) and Library and Information Science (MLIS) at the University of South Florida. His foundational undergraduate training includes a B.A. in Communication from Columbus State University and an A.S. in Pre-Pharmacy from Gordon College. Dr. Tarver further sharpened his expertise through two postdoctoral fellowships: one in Behavioral Oncology at Indiana University and another in Medical Informatics at the VA Medical Center in Indianapolis. These fellowships provided him with advanced training in clinical research, data analytics, and healthcare system improvement. His broad and deep academic background allows him to bridge clinical research, informatics, and patient-centered interventions—a combination that has enabled his innovative work in cancer disparities and technology-enhanced health solutions.

Professional Experience

Dr. Tarver’s professional journey is defined by a blend of academic, clinical, and administrative roles that support his contributions to cancer prevention, health equity, and public health informatics. Currently serving as an Assistant Professor in the Division of Cancer Prevention and Control within the Department of Internal Medicine at The Ohio State University, he has held this role since 2019. Prior to this appointment, he was a postdoctoral and informatics fellow at the Roudebush VA Medical Center and Indiana University–Purdue University Indianapolis. During his time at the VA, Dr. Tarver contributed to the Center for Health Information and Communication, refining his expertise in applying informatics to support equitable healthcare delivery. His professional roles also extend into quality improvement, where he co-led the Health Equity Core at OSU’s Quality Improvement Hub from 2022 to 2024. Dr. Tarver is an active mentor in OSU’s Center for Cancer Health Equity Summer Research Program, guiding underrepresented students in impactful, community-focused projects. In addition, he participates in institutional governance as a member of OSU’s Innovation Council. Across his roles, he has demonstrated consistent leadership, interdisciplinary collaboration, and a deep commitment to improving health outcomes through equitable and data-driven approaches.

Research Interests

Dr. Tarver’s research is driven by a deep commitment to eliminating disparities in cancer prevention and control through the integration of technology, public health, and clinical practice. His primary interest lies in the development and evaluation of patient-centered technologies—particularly electronic patient-reported outcomes (ePRO) tools—to better engage underserved populations and inform health system decision-making. His projects explore how these tools can be tailored to the unique needs of minority communities, improve cancer survivorship planning, and enhance real-time communication between patients and providers. Another major area of interest is health equity, where Dr. Tarver investigates the impact of perceived discrimination, systemic biases, and cultural barriers on cancer care utilization and outcomes. Additionally, he is involved in research that evaluates educational interventions designed to reduce STEM-related biases in high school learning environments. Through his interdisciplinary work, Dr. Tarver aims to generate actionable insights that not only contribute to academic knowledge but also guide policy reforms and clinical practices. His interests span behavioral oncology, implementation science, and medical informatics, positioning him at the forefront of translational research that impacts patient lives while advancing health equity on a systemic scale.

Research Skills

Dr. Tarver possesses a robust skill set in both qualitative and quantitative research methodologies, which he applies to projects at the intersection of health equity, informatics, and cancer prevention. He is highly experienced in designing and analyzing patient-reported outcomes (PROs), particularly within underserved and minority populations. His expertise includes conducting structured interviews, participant observation, and systematic reviews—skills he actively shares as a guest lecturer in OSU’s Public Health Informatics course. Dr. Tarver is also proficient in research related to intervention development and evaluation, including randomized trials and implementation science frameworks. His grant-writing capabilities are demonstrated by his role as Principal Investigator (PI) and Co-Investigator (Co-I) on several federal and institutional research awards. He collaborates across disciplines, including clinical medicine, education, behavioral science, and information systems, to build comprehensive research designs. Additionally, he has applied informatics tools for data visualization, regulatory decision-making, and game-based learning assessments. These skills empower him to execute complex, multilevel projects with real-world applicability and high translational value. His research toolkit is complemented by strong mentorship abilities, fostering new talent and promoting equity-focused research within academic and clinical settings.

Awards and Honors

Dr. Tarver has received multiple prestigious honors that reflect his academic excellence, research promise, and commitment to advancing health equity. He was honored with the Young Investigator Award at the VA Medical Center in Indianapolis, recognizing his early-career contributions to cancer prevention research. His selection for the VA Advanced Fellowship in Medical Informatics further highlights his potential as a leader in data-driven health solutions. As a fellow in Behavioral Oncology at Indiana University, he gained national recognition for his work integrating psychological, behavioral, and technological approaches to patient-centered care. Notably, he was a recipient of the Diversity Supplement from the National Cancer Institute (NCI) through the University of Alabama at Birmingham, affirming his focus on minority health and health disparities. Earlier in his academic journey, he was awarded the ALSTARS Scholarship at the University of South Florida for academic merit and leadership. These accolades not only reflect his dedication to research excellence but also underscore the national recognition he has received for addressing some of the most pressing challenges in health equity, cancer care, and public health education.

Conclusion

In conclusion, Dr. Willi L. Tarver stands out as an exceptionally well-rounded and impactful academic professional whose contributions significantly advance the fields of cancer prevention, public health informatics, and health equity. His ability to bridge research, mentorship, education, and clinical innovation uniquely qualifies him for the Best Researcher Award. Through interdisciplinary training, funded research projects, and active mentorship, Dr. Tarver continues to address real-world health disparities and improve patient outcomes, particularly in underserved communities. His track record as a Principal Investigator and collaborator on diverse research grants highlights his leadership and collaborative capabilities. Moreover, his mentorship of minority students and involvement in institutional quality improvement initiatives reflect a long-term investment in both people and systems. With a growing portfolio of honors, active society memberships, and educational contributions, Dr. Tarver is positioned for continued excellence and recognition in the academic and public health communities. His work exemplifies the values of translational research, social impact, and scientific integrity, making him a deserving and distinguished candidate for the Best Researcher Award.

Publications Top Notes

1. Family structure and risk behaviors: the role of the family meal in assessing likelihood of adolescent risk behaviors
📅 Year: 2014
✍️ Authors: S. Goldfarb, W.L. Tarver, B. Sen
📰 Psychology Research and Behavior Management, pp. 53–66
📈 Citations: 83

2. The use of cancer-specific patient-centered technologies among underserved populations in the United States: systematic review
📅 Year: 2019
✍️ Authors: W.L. Tarver, D.A. Haggstrom
📰 Journal of Medical Internet Research, 21(4), e10256
📈 Citations: 68

3. Growth dynamics of patient-provider internet communication: trend analysis using the Health Information National Trends Survey (2003 to 2013)
📅 Year: 2018
✍️ Authors: W.L. Tarver, T. Menser, B.W. Hesse, T.J. Johnson, E. Beckjord, E.W. Ford, et al.
📰 Journal of Medical Internet Research, 20(3), e109
📈 Citations: 56

4. A systematic review of the association between family meals and adolescent risk outcomes
📅 Year: 2015
✍️ Authors: S.S. Goldfarb, W.L. Tarver, J.L. Locher, J. Preskitt, B. Sen
📰 Journal of Adolescence, 44, pp. 134–149
📈 Citations: 56

5. Exploring disparities and variability in perceptions and self-reported colorectal cancer screening among three ethnic subgroups of US Blacks
📅 Year: 2010
✍️ Authors: C.K. Gwede, C.M. William, K.B. Thomas, W.L. Tarver, G.P. Quinn, et al.
📰 Oncology Nursing Forum, 37(5), 581
📈 Citations: 51

6. A randomized trial to compare a tailored web-based intervention and tailored phone counseling to usual care for increasing colorectal cancer screening
📅 Year: 2018
✍️ Authors: V.L. Champion, S.M. Christy, W. Rakowski, W.G. Gathirua-Mwangi, W.L. Tarver, et al.
📰 Cancer Epidemiology, Biomarkers & Prevention, 27(12), 1433–1441
📈 Citations: 35

7. The impact of health information technology on cancer care across the continuum: a systematic review and meta-analysis
📅 Year: 2016
✍️ Authors: W.L. Tarver, N. Menachemi
📰 Journal of the American Medical Informatics Association, 23(2), 420–427
📈 Citations: 35

8. Perceptions of colorectal cancer among three ethnic subgroups of US blacks: a qualitative study
📅 Year: 2011
✍️ Authors: C.K. Gwede, E. Jean-Francois, G.P. Quinn, S. Wilson, W.L. Tarver, K.B. Thomas, et al.
📰 Journal of the National Medical Association, 103(8), 669–680
📈 Citations: 35

9. Allostatic load: a framework to understand breast cancer outcomes in Black women
📅 Year: 2021
✍️ Authors: S. Obeng-Gyasi, W. Tarver, R.C. Carlos, B.L. Andersen
📰 NPJ Breast Cancer, 7(1), 100
📈 Citations: 34

10. Factors associated with adherence to mammography screening among insured women differ by income levels
📅 Year: 2018
✍️ Authors: W. Gathirua-Mwangi, A. Cohee, W.L. Tarver, A. Marley, E. Biederman, et al.
📰 Women’s Health Issues, 28(5), 462–469
📈 Citations: 34

Yana Zhang | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Assoc. Prof. Dr. Yana Zhang | Medicine and Dentistry | Best Researcher Award

Associate Professor from Department of Otolaryngology-Head and Neck Surgery, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

Dr. Yana Zhang is an accomplished academic and researcher in the field of Otorhinolaryngology–Head and Neck Surgery, currently serving as an Associate Professor at the Third Affiliated Hospital of Sun Yat-sen University. She holds a Ph.D. from Tongji Medical College, Huazhong University of Science and Technology, China, and has completed a postdoctoral fellowship at Northwestern University, USA. With over a decade of research and clinical experience, Dr. Zhang has established herself as a leading figure in allergy and airway inflammation research. Since joining Sun Yat-sen University through the prestigious “Hundred Talents Program” in 2020, she has been spearheading multiple high-impact research projects. She has published more than 40 peer-reviewed articles in journals such as Nature Immunology, J Allergy Clin Immunol, J Exp Med, and Am J Respir Crit Care Med, many as first or corresponding author. Her research focuses on the molecular mechanisms underlying allergic inflammation and chronic rhinosinusitis. Dr. Zhang plays influential roles in several national academic and medical committees and is a regular reviewer for high-impact journals and research foundations. Her work is recognized for its translational value, aiming to improve treatment outcomes for patients with allergic diseases and ENT disorders.

Professional Profile

Education

Dr. Yana Zhang pursued her higher education in medicine and specialized in Otorhinolaryngology–Head and Neck Surgery. She earned her Ph.D. from Tongji Medical College at Huazhong University of Science and Technology in 2014, one of China’s most respected institutions in medical research. Her doctoral work focused on immunological mechanisms and inflammatory processes in chronic rhinosinusitis and other airway-related disorders, laying the groundwork for her later research. She subsequently enhanced her academic portfolio by undertaking postdoctoral training at Northwestern University in the United States from 2016 to 2020. This international experience enabled her to refine her research methods and establish collaborations with world-renowned immunologists and clinical scientists. Her training at Northwestern offered her exposure to advanced biomedical research techniques and allowed her to integrate global best practices into her work. This comprehensive academic background has provided her with a solid foundation to pursue advanced research in translational medicine, particularly in immune-mediated diseases of the upper respiratory tract. Her education reflects a blend of rigorous Chinese medical training and cutting-edge international research exposure, positioning her as a global scholar with a deep understanding of both clinical and experimental approaches.

Professional Experience

Dr. Zhang began her professional academic career after completing her Ph.D. in 2014. Following this, she undertook a postdoctoral fellowship at Northwestern University in the United States from 2016 to 2020, where she worked on translational research projects focused on immunoregulation and inflammatory diseases. This experience significantly expanded her research expertise and network. In 2020, she returned to China to join the Third Affiliated Hospital of Sun Yat-sen University as an Associate Professor through the university’s highly competitive “Hundred Talents Program.” In this role, she leads a dynamic research team working on inflammatory mechanisms in chronic rhinosinusitis and allergy-related comorbidities. Dr. Zhang also holds several influential academic appointments, including expert reviewer roles for the Ministry of Education and the National Natural Science Foundation of China. She serves on various national committees under the Chinese Medical Association and other professional bodies, contributing to policy, research direction, and academic evaluations. She also plays a key role in mentoring graduate students and guiding young researchers. Her multidisciplinary experience bridges clinical practice and molecular science, allowing her to translate laboratory findings into potential therapies for ENT and allergic conditions.

Research Interests

Dr. Yana Zhang’s research centers on immunological mechanisms and therapeutic strategies targeting eosinophilic inflammation and allergic airway diseases. Her work addresses chronic rhinosinusitis with nasal polyps (CRSwNP), a debilitating and recurring inflammatory disorder, and aims to unravel the molecular underpinnings of steroid resistance and epithelial barrier dysfunction. She has explored novel pathways involving fatty acids, IL-17A, vitamin D, and extracellular vesicles in allergic disease models. Her recent studies investigate the roles of epithelium-derived chemokines, Charcot-Leyden crystals, and immune checkpoints in modulating inflammation and tissue remodeling. Another central focus of her research is the interaction between environmental factors, such as air pollution, and the immunopathology of rhinitis and asthma. Dr. Zhang’s goal is to translate her laboratory findings into effective therapeutic strategies that can be applied in clinical settings. Her research also spans the field of immune metabolism, including succinate signaling and its effect on regulatory T cells, with implications for systemic autoimmune and allergic diseases. Her interdisciplinary work combines molecular biology, clinical otorhinolaryngology, and immunotherapy to address urgent healthcare challenges in allergy and airway inflammation.

Research Skills

Dr. Zhang is equipped with a comprehensive skill set in both clinical and molecular research. Her expertise includes cellular immunology, molecular biology, transcriptomics, histopathology, and translational medicine. She is proficient in designing and conducting in vivo and in vitro models of airway inflammation, including murine models of eosinophilic rhinosinusitis. She has extensive experience in flow cytometry, ELISA, immunohistochemistry, RNA sequencing, confocal microscopy, and CRISPR-Cas9 gene editing technologies. Her postdoctoral training at Northwestern University further enhanced her proficiency in advanced immunological assays, including Treg stability assays, metabolite analysis, and cell differentiation studies. Dr. Zhang is skilled in developing predictive models and statistical algorithms to interpret clinical outcomes and endotypes in allergic patients. Additionally, she collaborates with bioinformatics experts to analyze large datasets, facilitating biomarker discovery and patient stratification. Her capacity to bridge bench-side experimentation with clinical relevance makes her a leader in translational allergy research. Dr. Zhang’s multidisciplinary research environment allows her to apply both clinical acumen and lab-based expertise to uncover new therapeutic avenues in chronic inflammatory diseases.

Awards and Honors

Dr. Yana Zhang has received multiple accolades that reflect her scholarly excellence and leadership in biomedical research. Most notably, she was selected as a Young Top Talent under the Guangdong “Pearl River Talent Program” in 2022, a prestigious recognition for emerging scientific leaders in China. In 2020, she was recruited through the “Hundred Talents Program” at Sun Yat-sen University, a national initiative to attract top researchers to Chinese academic institutions. These honors underscore her scientific impact and potential to contribute to national innovation goals. In addition to these major recognitions, Dr. Zhang has been invited to serve as a grant reviewer for the National Natural Science Foundation of China, a testament to her credibility and leadership in the scientific community. She is also an expert evaluator for doctoral dissertations under the Ministry of Education. Her editorial and peer-review responsibilities for internationally reputed journals further reflect her standing in the academic field. Collectively, these awards and responsibilities highlight her commitment to advancing research, mentoring junior scientists, and shaping the future of otorhinolaryngology and immunology in China and beyond.

Conclusion

Dr. Yana Zhang stands out as an exceptional researcher and academic whose work has had a profound impact on the field of immunology and otorhinolaryngology. Her career reflects a harmonious blend of rigorous academic training, international experience, and a deep commitment to translational medicine. Through cutting-edge research on eosinophilic inflammation and allergic diseases, she has significantly advanced our understanding of the pathophysiological mechanisms underlying chronic airway disorders. Her contributions are well-documented through a robust portfolio of publications in top-tier scientific journals and her leadership in multiple national research projects. Furthermore, her active involvement in academic societies and committees showcases her dedication to the scientific community. Dr. Zhang’s efforts not only enhance clinical outcomes for patients but also influence national policy and research directions. Her vision of integrating basic research with clinical application makes her a key figure in developing personalized treatments for allergy and ENT disorders. With continued support and collaboration, Dr. Zhang is poised to make even greater strides in medical science and to serve as a role model for future researchers in China and globally.

Publications Top Notes

  1. Vitamin D impedes eosinophil chemotaxis via inhibiting glycolysis‑induced CCL26 expression in eosinophilic chronic rhinosinusitis with nasal polyps

  • Year: 2025

  • Authors: Weiqiang Huang, Yana Zhang, Yue Li, Junming Ma, Xia Li, Yanjie Jiang, Jianqi Wang, Haotian Wu, Xiaohong Chen, Zizhen Huang, Xifu Wu, Xiaoping Lai, Donglin Li, Lihong Chang, Gehua Zhang

2. Succinate drives gut inflammation by promoting FOXP3 degradation through a molecular switch

  • Year: 2025

  • Authors: Hai Wang, Danqing Hu, Yang Cheng, Qiong Gao, Kun Liu, Nikita L. Mani, Amy Y. Tang, Radhika Iyer, Beixue Gao, Leyu Sun, Qi Zhou, Qin Yu, Samuel E. Weinberg, Xiaoyu Zhang, Yingzi Cong, Parambir S. Dulai, Yana Zhang, Zheng Liu, Deyu Fang